The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Axcella Health Inc | COM | 05454B105 | 55,873 | 6,001,362 | SH | DFND | 2 | 0 | 6,001,362 | 0 | |
| Axcella Health Inc | COM | 05454B105 | 25,575 | 2,747,052 | SH | DFND | 0 | 2,747,052 | 0 | ||
| Denali Therapeutics Inc | COM | 24823R105 | 166,199 | 8,005,747 | SH | DFND | 1 | 0 | 8,005,747 | 0 | |
| Evelo Biosciences Inc | COM | 299734103 | 26,672 | 2,970,119 | SH | DFND | 2 | 0 | 2,970,119 | 0 | |
| Evelo Biosciences Inc | COM | 299734103 | 91,643 | 10,205,282 | SH | DFND | 1 | 0 | 10,205,282 | 0 | |
| Evelo Biosciences Inc | COM | 299734103 | 45,421 | 5,058,002 | SH | DFND | 0 | 5,058,002 | 0 | ||
| Kaleido Biosciences Inc | COM | 483347100 | 113,216 | 9,759,979 | SH | DFND | 1 | 0 | 9,759,979 | 0 | |
| Kaleido Biosciences Inc | COM | 483347100 | 11,484 | 989,976 | SH | DFND | 2 | 0 | 989,976 | 0 | |
| Kaleido Biosciences Inc | COM | 483347100 | 76,685 | 6,610,755 | SH | DFND | 0 | 6,610,755 | 0 | ||
| Moderna Inc | COM | 60770K107 | 860,883 | 58,803,455 | SH | DFND | 2 | 0 | 58,803,455 | 0 | |
| Moderna Inc | COM | 60770K107 | 57 | 3,924 | SH | DFND | 0 | 3,924 | 0 | ||
| Quanterix Corp | COM | 74766Q101 | 61,681 | 1,825,412 | SH | DFND | 0 | 1,825,412 | 0 | ||
| Rubius Therapeutics Inc | COM | 78116T103 | 182,135 | 11,578,828 | SH | DFND | 1 | 0 | 11,578,828 | 0 | |
| Rubius Therapeutics Inc | COM | 78116T103 | 379,942 | 24,153,995 | SH | DFND | 2 | 0 | 24,153,995 | 0 | |
| Rubius Therapeutics Inc | COM | 78116T103 | 40,327 | 2,563,703 | SH | DFND | 0 | 2,563,703 | 0 | ||
| Seres Therapeutics Inc | COM | 81750R102 | 40,839 | 12,682,876 | SH | DFND | 2 | 0 | 12,682,876 | 0 | |
| Seres Therapeutics Inc | COM | 81750R102 | 28,622 | 8,888,888 | SH | DFND | 0 | 8,888,888 | 0 | ||
| Syros Pharmaceuticals Inc | COM | 87184Q107 | 29,673 | 3,204,437 | SH | DFND | 2 | 0 | 3,204,437 | 0 | |
| TransMedics Group Inc | COM | 89377M109 | 42,591 | 1,469,173 | SH | DFND | 2 | 0 | 1,469,173 | 0 | |
| TransMedics Group Inc | COM | 89377M109 | 30,761 | 1,061,102 | SH | DFND | 0 | 1,061,102 | 0 | ||